A complete myocardial perfusion imaging protocol guide for nuclear medicine technologists — covering patient prep, stress protocols, acquisition, processing, and artifact recognition.

Myocardial Perfusion Imaging: Protocol Guide for Nuclear Medicine Technologists

Myocardial perfusion imaging (MPI) is the most widely performed nuclear cardiology procedure, and the nuclear medicine technologist’s role extends far beyond injecting a tracer and acquiring images. From pre-procedure screening to pharmacologic stress management to artifact identification during processing, MPI demands a high level of clinical judgment, protocol knowledge, and patient management skill.

This guide covers the full workflow — the kind of detail you would want before walking into a new nuclear cardiology lab or reviewing your department’s standing protocols.


Clinical Indications and Referral Context

Understanding why a patient was referred helps you anticipate protocol variations and communicate effectively with the ordering cardiologist.

Primary indications for MPI:

  • Detection and localization of coronary artery disease (CAD)
  • Risk stratification in patients with known or suspected CAD
  • Assessment of myocardial viability post-infarction
  • Evaluation of physiologic significance of intermediate coronary stenoses
  • Post-revascularization follow-up (CABG or PCI)

MPI answers two essential questions: Is there a perfusion defect? If so, is it fixed (scar) or reversible (ischemia)? Answering those questions accurately depends entirely on optimal patient preparation, an appropriate stress mode, correct tracer timing, and artifact-free acquisition.


Radiopharmaceuticals Used in SPECT MPI

The two dominant tracers for SPECT MPI are both Tc-99m-labeled agents, which have largely replaced Tl-201 for routine imaging due to superior image quality and lower patient radiation dose.

TracerMechanismImaging Delay (Rest)Imaging Delay (Stress)Notes
Tc-99m Sestamibi (MIBI)Passive diffusion; mitochondrial uptake45–60 min15–30 minMinimal redistribution; allows stress/rest on same day
Tc-99m TetrofosminSimilar to MIBI; faster hepatic clearance30–45 min15–30 minLower liver background; faster protocols possible
Thallium-201Active transport via Na/K ATPase10–15 minRedistributes over 3–4 hoursLower photon energy; higher dose; used for viability

Same-day protocol note: When using Tc-99m agents for a same-day rest/stress or stress/rest protocol, the stress dose is administered at 2.5–3× the rest dose to prevent shine-through from the residual rest tracer.


Patient Preparation

Proper preparation is a prerequisite to interpretable images. Cutting corners here creates artifacts that are indistinguishable from true perfusion defects.

Dietary Restrictions

  • NPO for 4–6 hours prior to stress injection (reduces competing hepatic uptake for MIBI/tetrofosmin)
  • No caffeine for 12 hours if pharmacologic vasodilator stress is planned — caffeine and theophylline antagonize adenosine receptors and will attenuate or abolish the hemodynamic response
  • Low-carbohydrate, high-protein meal the evening before — reduces subdiaphragmatic bowel and hepatic interference

Medication Holds

  • Beta-blockers and calcium channel blockers: Hold 24–48 hours before exercise stress if a diagnostic test is desired. For pharmacologic stress, these medications affect heart rate but not the vasodilatory response — discuss with the ordering physician
  • Dipyridamole and theophylline-containing medications: Hold for at least 48 hours before regadenoson or adenosine stress
  • Nitrates: Typically continued; discuss with cardiologist for viability protocols
  • Diabetic medications: Coordinate carefully, especially for patients on insulin — fasting combined with stress testing poses hypoglycemia risk

Patient Screening Checklist

Before proceeding to stress, verify:

  • [ ] Blood pressure and heart rate within acceptable limits (typically BP < 180/110, HR < 100 bpm at rest)
  • [ ] No contraindications to the planned stress modality
  • [ ] 12-lead ECG reviewed by supervising physician or per protocol
  • [ ] IV access established and patent
  • [ ] Emergency equipment and reversal agents available (aminophylline for adenosine/regadenoson; atropine for dobutamine)

Stress Protocols

The selection of stress modality is determined by the patient’s functional capacity, comorbidities, and the diagnostic question. Always confirm the stress mode with the ordering cardiologist if ambiguous.

Exercise Stress

Exercise is the preferred stress modality for patients who can achieve ≥85% of maximum predicted heart rate (MPHR = 220 − age). It provides hemodynamic and ECG data that add diagnostic value beyond perfusion alone.

Standard Bruce Protocol:

  • Begins at 1.7 mph, 10% grade (Stage 1)
  • Increases in speed and grade every 3 minutes
  • Target: ≥85% MPHR; minimum meaningful exercise is ≥4–6 minutes

Tracer injection timing:

  • Inject tracer at 85% MPHR or at peak exercise when exercise cannot be sustained longer
  • Patient should continue exercising for 60–90 seconds post-injection to allow first-pass myocardial extraction
  • Imaging begins 15–30 minutes post-injection (Tc-99m agents)

Modified Bruce and Cornell Protocols reduce the initial workload for deconditioned patients while still achieving diagnostic endpoints.

Pharmacologic Stress: Vasodilators

Vasodilator stress is indicated when the patient cannot achieve adequate exercise due to:

  • Peripheral vascular disease, musculoskeletal limitations, deconditioning
  • LBBB or ventricular-paced rhythm (exercise-induced rate-dependent perfusion artifacts in these patients make vasodilator preferred)
  • Inability to attain target heart rate with exercise

Regadenoson (Lexiscan) is the most commonly used vasodilator in the United States, having largely replaced adenosine in most labs.

ParameterRegadenosonAdenosine
MechanismSelective A2A receptor agonistNon-selective adenosine agonist
Dose0.4 mg (5 mL) rapid IV bolus (~10 sec)140 mcg/kg/min infusion × 6 min
Tracer timingInject 10–20 sec after regadenosonInject at midpoint (3 min into infusion)
Saline flush5 mL immediately afterN/A
Half-life (initial)2–4 minutes< 10 seconds
Side effect profileDyspnea, flushing, headache, chest discomfortSimilar; more frequent with adenosine
Reversal agentAminophylline 50–250 mg slow IV pushAminophylline; discontinue infusion
Caffeine restriction12 hours12 hours

Absolute contraindications for regadenoson:

  • Second- or third-degree AV block without functioning pacemaker
  • Sinus node dysfunction without pacemaker
  • Systolic BP < 90 mmHg
  • Known hypersensitivity to regadenoson or adenosine

Monitoring during regadenoson stress:

  • Continuous ECG monitoring
  • 12-lead ECG every minute
  • BP every minute during infusion and for 3–5 minutes post-injection until stable
  • Have aminophylline drawn and ready before administering regadenoson

Low-level exercise augmentation: For ambulatory patients undergoing regadenoson stress, walking at 1.7 mph, 0% grade for 90 seconds before and 2 minutes after injection reduces subdiaphragmatic tracer uptake and improves image quality. This is not recommended in patients with LBBB, WPW, or ventricular pacing.

Pharmacologic Stress: Dobutamine

Dobutamine is a catecholamine that increases heart rate and myocardial oxygen demand through beta-1 receptor stimulation. It is reserved for patients who cannot undergo vasodilator stress (e.g., severe COPD, recent caffeine ingestion, critical carotid stenosis) and is less commonly used than vasodilators in nuclear cardiology.

Dobutamine infusion protocol:

  • Begin at 5 mcg/kg/min; increase by 5–10 mcg/kg/min every 3 minutes
  • Maximum dose: 40–50 mcg/kg/min
  • Atropine (0.25–1.0 mg IV) may be added if target heart rate is not achieved
  • Inject tracer 1 minute after reaching target heart rate

Contraindications: Unstable angina, recent MI (< 2–4 days), uncontrolled hypertension, aortic dissection, significant arrhythmias.


SPECT Acquisition Parameters

Standardized acquisition parameters reduce inter-study variability and ensure reproducible quantitative analysis. The following reflects ASNC-recommended parameters for Tc-99m SPECT MPI:

ParameterRecommended Value
Camera arc180° (RAO 45° to LPO 45°)
Number of projections64 projections at 3° intervals (or 32 at 6°)
Dwell time25–35 seconds per stop (Tc-99m agents)
Matrix size64 × 64 or 128 × 128
Gating8 or 16 bins per R-R interval
Zoom1.0–1.5 (larger zoom for small-hearts)
Energy window140 keV ± 10% (Tc-99m)
CollimatorLow-energy high-resolution (LEHR)

Gated SPECT is standard of care. In addition to perfusion, gated acquisition provides wall motion and ejding fraction data — a transient ischemic dilation (TID) pattern on stress vs. rest, or post-stress stunning (reduced EF at stress compared to rest), adds significant prognostic information.

Patient positioning:

  • Arms above the head; use arm supports to prevent motion
  • Left arm in particular must be elevated to prevent attenuation
  • Instruct patient to breathe normally and minimize movement
  • Review projection images before the patient leaves the table — motion correction after the fact is imperfect

Image Reconstruction and Processing

Raw projection data must be reconstructed before interpretation. Most nuclear cardiology labs use filtered back projection (FBP) or iterative reconstruction (ordered subset expectation maximization, OSEM), with the latter now standard on modern systems due to superior noise reduction and contrast.

Standard reconstruction workflow:

  1. Apply appropriate filter (e.g., Butterworth filter with cutoff and order matched to tracer and system)
  2. Reconstruct transaxial slices
  3. Reorient into cardiac short-axis, horizontal long-axis, and vertical long-axis planes
  4. Apply attenuation correction (AC) if available — hardware-based CT AC or software-based methods
  5. Generate polar maps (bull’s-eye plots) for quantitative comparison against age/sex-matched normals
  6. Review gated cine for wall motion and calculate LVEF

Software tools: QPS/QGS (Cedars-Sinai), 4DM (INVIA), and XELERIS (GE) are the dominant platforms. Familiarity with the reorientation tools in your specific software is essential — incorrect cardiac axis alignment will produce false-positive defects.


Common Artifacts and How to Recognize Them

Artifact recognition is arguably the highest-value skill a nuclear cardiology technologist can develop. Misidentifying an artifact as a perfusion defect can trigger unnecessary cardiac catheterization.

ArtifactAppearanceCauseMitigation
Inferior wall attenuation (males)Fixed inferior defectSubdiaphragmatic attenuationProne imaging; attenuation correction
Anterior/lateral attenuation (females)Fixed anterolateral defectBreast tissue attenuationBreast marker; AC; prone imaging
Patient motionStreak artifacts; misalignment in cinePatient movement during acquisitionRe-image; motion correction software
Subdiaphragmatic activityLiver/bowel hot spot near inferior wall**High hepatic MIBI uptakeFatty/water snack post-injection; delay imaging
Upward creepInferior wall “brightening” on sequential framesRespiratory drift after exerciseAdequate post-exercise delay before imaging
Soft tissue truncationCounts loss at field of view edgePatient too large for detector windowAdjust camera head positioning
LBBB patternSeptal defect on stress, resolves at restRate-dependent septal motion abnormalityVasodilator stress preferred; avoid exercise

Prone imaging is a practical, low-cost artifact reduction technique: repositioning the patient prone causes inferior wall subdiaphragmatic structures to shift away, confirming or refuting an inferior defect. If the inferior defect resolves in prone, it is almost certainly attenuation artifact.


Stress/Rest Interpretation Overview for Technologists

While interpretation is the cardiologist’s or nuclear medicine physician’s responsibility, a knowledgeable technologist who can pre-review images provides an essential quality check before the physician reads.

Normal study: Uniform tracer distribution throughout left ventricular myocardium at both stress and rest; normal wall motion and EF on gated images.

Reversible defect (ischemia): Perfusion defect present on stress images that fills in on rest — indicates viable myocardium with stress-inducible ischemia.

Fixed defect (scar): Defect present on both stress and rest images — consistent with prior myocardial infarction.

Mixed pattern: Partial fill-in — combination of scar and peri-infarct ischemia.

Transient ischemic dilation (TID): Apparent LV cavity enlargement at stress relative to rest — marker of severe CAD (typically multivessel disease or proximal LAD territory).


Quality Control and Documentation

Every technologist-controlled step in the workflow should be documented. Nuclear cardiology labs under Joint Commission or IAC accreditation are expected to maintain:

  • Tracer dose records (activity, lot number, expiration, administered activity, time of administration)
  • Patient weight and height (used for dose-per-body-weight protocols)
  • Blood pressure and heart rate logs throughout the procedure
  • ECG strips documenting baseline, peak stress, and recovery
  • Adverse event documentation, including any use of reversal agents
  • Image quality review notation — motion detected, reimage performed, prone images acquired

A complete procedure log protects the patient, documents your clinical decision-making, and satisfies regulatory requirements under NRC 10 CFR 35.


Conclusion

Myocardial perfusion imaging is a technically demanding procedure in which the technologist’s preparation, stress management, and acquisition decisions directly determine image quality and, ultimately, the accuracy of the diagnostic report. Mastery of pharmacologic stress protocols — particularly regadenoson administration and monitoring — patient preparation requirements, acquisition parameter selection, and artifact recognition elevates your contribution from task execution to true clinical partnership.

Continuing education in nuclear cardiology — through ASNC-endorsed resources, SNMMI technologist section materials, and NMTCB-approved CE — ensures your protocol knowledge stays current as guidelines and equipment evolve.

Want to earn CE credits in nuclear cardiology and MPI protocols? See our guide to CE resources for nuclear medicine technologists and compare top NMTCB-approved platforms.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top